Clinical Trials Directory

Trials / Completed

CompletedNCT02587403

A Comparison of Fortiva and Strattice Tissue Matrices in Complex, Ventral Hernia Repair

A Randomized, Prospective Study Comparing Fortiva™ Porcine Dermis vs. Strattice™ Reconstructive Tissue Matrix in Patients Undergoing Complex Open Primary Ventral Hernia Repair

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
RTI Surgical · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.

Detailed description

This is a randomized, prospective, double-blinded study evaluating the efficacy of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix in 120 patients with large complex abdominal wall ventral hernias undergoing single stage repair. The patient will be blinded to treatment as well as an independent qualified evaluator to confirm evidence of reoccurrence. This post-market study compares two FDA cleared biologic hernia materials. Fortiva™ porcine dermis, processed by RTI Surgical, Inc., a non-cross linked porcine dermis will be compared to Strattice™ Reconstructive Tissue Matrix by Life Cell, a non-cross linked porcine dermis for reinforcement during the single stage open reconstruction of abdominal wall defects. The primary outcome will be hernia recurrence at 1 year. Outcomes will be evaluated at 6 weeks, 3 months, 6 months and 12 months and 24 months.

Conditions

Interventions

TypeNameDescription
DEVICEFortiva™ Porcine DermisFortiva Porcine Dermis implantation during repair of complex ventral hernia
DEVICEStrattice™ Reconstructive Tissue MatrixStrattice tissue matrix implanted during repair of complex ventral hernia

Timeline

Start date
2015-12-02
Primary completion
2023-09-19
Completion
2023-09-19
First posted
2015-10-27
Last updated
2024-12-27
Results posted
2024-12-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02587403. Inclusion in this directory is not an endorsement.